Welcome to our dedicated page for AIXIN LIFE INTL news (Ticker: AIXN), a resource for investors and traders seeking the latest updates and insights on AIXIN LIFE INTL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AIXIN LIFE INTL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AIXIN LIFE INTL's position in the market.
AiXin Life International, Inc. (AIXN) has launched a new anti-bacterial agent developed with Sichuan Zhongyixin New Material Co., Ltd. This product, unveiled at the Chengdu AiXin Shangyan Hotel, is designed to help combat Covid-19 and has shown 99.99% effectiveness against the Delta variant as per tests by the Chinese Academy of Sciences. AIXN serves as the exclusive sales agent for this product in China, aiming to meet market demand while also donating supplies to local communities. The company emphasizes its commitment to Covid-19 prevention and the well-being of the public.
Aixin Life International, Inc. (AIXN) has completed the acquisition of a hotel in Chengdu for approximately $1.16 million and nine pharmacies for about $5.31 million. These acquisitions aim to diversify Aixin's business and enhance operational synergies. Financial results for Q3 2021 show revenue increased by 12% year-over-year to $812,910, driven by growth in advertising and new revenue from the hotel and pharmacies. However, the company reported an operational loss of $(93,509) in Q3, reflecting rising costs. Overall, the hotel and pharmacy divisions are expected to accelerate business expansion.
AiXin Life International, Inc. (AIXN) has announced the purchase of the Shangyan Hotel in Chengdu for approximately $1.2 million and a chain of nine pharmacies for about $5.3 million. The hotel, with over 8,000 square meters, offers extensive facilities including 108 guest rooms and advanced amenities. The pharmacies, operating in Chengdu since 2016, will diversify AIXN's health product offerings and sales channels. The acquisitions aim to create synergies, improve efficiency, and boost future growth, with expected closings by July 2021.
AiXin Life International (AIXN) participated in the "China Healthcare & Nutrition Industry Development Forum" on May 17, 2021. The event featured key speakers discussing the future of healthcare and nutrition in China, emphasizing the shift towards preventive health and lifestyle management. AIXN's Chairman, Lin Quanzhong, expressed the company's commitment to promoting health awareness and a healthy lifestyle. The forum attracted over 100 corporate representatives, indicating strong industry engagement.
FAQ
What is the market cap of AIXIN LIFE INTL (AIXN)?
